← Leaderboards
Neil W. Schluger
Columbia University Health Sciences
$4,200,595
Attributed
$4,384,397
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $432.6K · FY2005–20$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,384,397 · 6
By mechanism
N01$1,788,168 · 1
T32$1,337,962 · 2
K24$1,204,363 · 1
P30$32,898 · 1
M01$21,006 · 1
Top collaborators
- R Graham Barr2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- R Graham Barr$40,525,821
- Ira A Tabas$44,847,082
- Jeanine M D'armiento$14,757,679
- Michio Hirano$20,704,569
- Elizabeth Oelsner$8,015,868
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchTuberculosisHuman Therapy EvaluationHuman SubjectLeukocyte Activation /TransformationInhalation Drug AdministrationImmunotherapyInterferon GammaOutcomes ResearchRespiratory Disorder ChemotherapyClinical TrialsTrainingMycobacterium TuberculosisRespiratory Disease /Disorder TherapyAntigen Presenting CellMemberClinical Trial Phase IAerosolsFlow CytometryAlveolar MacrophagesHiv InfectionsBactericidal ImmunityChemokineEnzyme Linked Immunosorbent Assay
Grant awards (23)
Training Program in Population Science of Respiratory Diseases$276,945
T32 · FY2020 · HL
Training Program in Population Science of Respiratory Diseases$90,660
T32 · FY2019 · HL
Mentoring in Tuberculosis Patient-Oriented Research$152,362
K24 · FY2009 · HL · contact PI
Mentoring in Tuberculosis Patient-Oriented Research$152,290
K24 · FY2008 · HL · contact PI
Training in Translational Lung Research$104,345
T32 · FY2008 · HL · contact PI
Training in Translational Lung Research$247,432
T32 · FY2007 · HL · contact PI
Mentoring in Tuberculosis Patient-Oriented Research$152,222
K24 · FY2007 · HL · contact PI
Respiratory Research Core$32,898
P30 · FY2007 · ES · contact PI
Training in Translational Lung Research$247,432
T32 · FY2006 · HL · contact PI
Mentoring in Tuberculosis Patient-Oriented Research$150,077
K24 · FY2006 · HL · contact PI
Training in Translational Lung Research$247,432
T32 · FY2005 · HL
Mentoring in Tuberculosis Patient-Oriented Research$146,492
K24 · FY2005 · HL
Training in Translational Lung Research$123,716
T32 · FY2004 · HL
CLINICAL INVESTIGATIONS IN LUNG HOST DEFENSES$112,730
K24 · FY2003 · HL
CLINICAL INVESTIGATIONS IN LUNG HOST DEFENSES$112,730
K24 · FY2002 · HL
AEROSOL DELIVERY OF THERAPEUTIC DRUGS TO PATIENTS WITH TUBERCULOSIS$0
M01 · FY2002 · RR
CLINICAL INVESTIGATIONS IN LUNG HOST DEFENSES$112,730
K24 · FY2001 · HL
AEROSOL DELIVERY OF THERAPEUTIC DRUGS TO PATIENTS WITH TUBERCULOSIS$0
M01 · FY2001 · RR
FEASIBILTIY STUDIES ON RETINOID TREATMENT IN EMPHYSEMA$1,504,314
N01 · FY2000 · HR
FEASIBILTIY STUDIES ON RETINOID TREATMENT IN EMPHYSEMA$283,854
N01 · FY2000 · HR
CLINICAL INVESTIGATIONS IN LUNG HOST DEFENSES$112,730
K24 · FY2000 · HL
AEROSOL DELIVERY OF THERAPEUTIC DRUGS TO PATIENTS WITH TUBERCULOSIS$21,006
M01 · FY2000 · RR
AEROSOL DELIVERY OF THERAPEUTIC DRUGS TO PATIENTS WITH TUBERCULOSIS$0
M01 · FY2000 · RR